Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward
Open Access
- 23 January 2024
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 64 (1) , 33-51
Abstract
Interindividual variability in genes encoding drug-metabolizing enzymes, transporters, receptors, and human leukocyte antigens has a major impact on a patient's response to drugs with regard to efficacy and safety. Enabled by both technological and conceptual advances, the field of pharmacogenomics is developing rapidly. Major progress in omics profiling methods has enabled novel genotypic and phenotypic characterization of patients and biobanks. These developments are paralleled by advances in machine learning, which have allowed us to parse the immense wealth of data and establish novel genetic markers and polygenic models for drug selection and dosing. Pharmacogenomics has recently become more widespread in clinical practice to personalize treatment and to develop new drugs tailored to specific patient populations. In this review, we provide an overview of the latest developments in the field and discuss the way forward, including how to address the missing heritability, develop novel polygenic models, and further improve the clinical implementation of pharmacogenomics.Keywords
This publication has 125 references indexed in Scilit:
- Orbitrap Mass SpectrometryAnalytical Chemistry, 2013
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorderNature, 2009
- Real-Time DNA Sequencing from Single Polymerase MoleculesScience, 2009
- Estimating coverage and power for genetic association studies using near-complete variation dataNature Genetics, 2008
- Evaluation of coverage variation of SNP chips for genome-wide association studiesEuropean Journal of Human Genetics, 2008
- Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and futureTrends in Pharmacological Sciences, 2004
- Multiplexed genotyping with sequence-tagged molecular inversion probesNature Biotechnology, 2003
- MALDI-TOF Mass Spectrometry-Based Snp GenotypingPharmacogenomics, 2002
- Solanidine is Present in Sera of Healthy Individuals and in Amounts Dependent on their Dietary Potato ConsumptionHuman Toxicology, 1985
- Inherited Taste DeficiencyScience, 1931